The common cold

Lancet

Volumn 361, Issue 9351, 2003, Pages 51-59

  Heikkinen, Terho ^a   Järvinen, Asko ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VACCINE;

COMMON COLD; CONFERENCE PAPER; DISEASE PREDISPOSITION; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; INFLAMMATION; MEDICAL RESEARCH; METAPNEUMOVIRUS; PRIORITY JOURNAL; RHINOVIRUS; VIRUS CELL INTERACTION; VIRUS DETECTION;

EID: 0037417511     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12162-9     Document Type: Conference Paper

References (148)

1. Herbert A.P. The common cold. Look back and laugh. 1960;115-117 Methuen, London.
2. Gonzales R., Malone D.C., Maselli J.H., Sande M.A. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 33:2001;757-762.
3. Adams P.F., Hendershot G.E., Marano M.A. Current estimates from the National Health Interview Survey. Vital Health Stat. 10:1999;1996.
4. Fox J.P., Hall C.E., Cooney M.K., Luce R.E., Kronmal R.A. The Seattle virus watch, 2: objectives, study population and its observation, data processing and summary of illnesses. Am J Epidemiol. 96:1972;270-285.
5. Monto A.S., Ullman B.M. Acute respiratory illness in an American community: the Tecumseh study. JAMA. 227:1974;164-169.
6. Monto A.S., Sullivan K.M. Acute respiratory illness in the community: frequency of illness and the agents involved. Epidemiol Infect. 110:1993;145-160.
7. Monto A.S. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev. 16:1994;351-373.
8. Arruda E., Pitkäranta A., Witek T.J. Jr, Doyle C.A., Hayden F.G. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol. 35:1997;2864-2868.
9. Mäkelä M.J., Puhakka T., Ruuskanen O., et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 36:1998;539-542.
10. Monto A.S., Bryan E.R., Ohmit S. Rhinovirus infections in Tecumseh, Michigan: frequency of illness and numbers of serotypes. J Infect Dis. 156:1987;43-49.
11. Vesa S., Kleemola M., Blomqvist S., et al. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J. 20:2001;574-581.
12. Gwaltney J.M. Jr. The common cold. Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious diseases. 5th edn:2000;651-665 Churchill Livingstone, Philadelphia.
13. Larson H.E., Reed S.E., Tyrrell D.A.J. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol. 5:1980;221-229.
14. Nicholson K.G., Kent J., Hammersley V., Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burdenl. BMJ. 315:1997;1060-1064.
15. van den Hoogen B.G., de Jong J.C., Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 7:2001;719-724.
16. Nissen M.D., Siebert D.J., Mackay I.M., Sloots T.P., Withers S.J. Evidence of human metapneumovirus in Australian children. Med J Aust. 176:2002;188.
17. Peret T.C.T., Boivin G., Li Y., et al. Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis. 185:2002;1660-1663.
18. Drews A.L., Atmar R.L., Glezen W.P., et al. Dual respiratory virus infections. Clin Infect Dis. 25:1997;1421-1429.
19. Johnston S.L., Sanderson G., Pattemore P.K., et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol. 31:1993;111-117.
20. Nokso-Koivisto J., Kinnari T.J., Lindahl P., Hovi T., Pitkäranta A. Human picornavirus and coronavirus RNA in nasopharynx of children without concurrent respiratory symptoms. J Med Virol. 66:2002;417-420.
21. Wald E.R., Dashefsky B., Byers C., Guerra N., Taylor F. Frequency and severity of infections in day care. J Pediatr. 112:1988;540-546.
22. Alho O.P., Koivu M., Sorri M., Rantakallio P. Risk factors for recurrent acute otitis media and respiratory infection in infancy. Int J Pediatr Otorhinolaryngol. 19:1990;151-161.
23. Ball T.M., Holberg C.J., Aldous M.B., Martinez F.D., Wright A.L. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med. 156:2002;121-126.
24. Casselbrant M.L., Mandel E.M., Fall P.A., et al. The heritability of otitis media: a twin and triplet study. JAMA. 282:1999;2125-2130.
25. Pitkäranta A., Nokso-Koivisto J., Jäntti V., et al. Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children. J Clin Virol. 14:1999;199-205.
26. Cohen S., Tyrrell D.A.J., Smith A.P. Psychological stress and susceptibility to the common cold. N Engl J Med. 325:1991;606-612.
27. Nieman D.C. Exercise, upper respiratory tract infection, and the immune system. Med Sci Sports Exerc. 26:1994;128-139.
28. Gwaltney J.M. Jr, Hendley J.O., Simon G., Jordan W.S. Jr. Rhinovirus infections in an industrial population, 1: the occurrence of illness. N Engl J Med. 275:1966;1261-1268.
29. Monto A.S., Shope T.C., Schwartz S.A., Albrecht J.K. Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection. J Infect Dis. 154:1986;128-133.
30. Blomqvist S., Roivainen M., Puhakka T., Kleemola M., Hovi T. Virological and serological analysis of rhinovirus infections during the first two years of life in a cohort of children. J Med Virol. 66:2002;263-268.
31. Monto A.S., Cavallaro J.J. The Tecumseh study of respiratory illness, 2: patterns of occurrence of infection with respiratory pathogens, 1965-1969. Am J Epidemiol. 94:1971;280-289.
32. Waris M. Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B. J Infect Dis. 163:1991;464-469.
33. Izurieta H.S., Thompson W.W., Kramarz P., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 342:2000;232-239.
34. Nicholson K.G. Human influenza. Nicholson K.G., Webster R.G., Hay A.J. Textbook of influenza. 1998;219-264 Blackwell Science, Oxford.
35. Gwaltney J.M. Jr, Moskalski P.B., Hendley J.O. Hand-to-hand transmission of rhinovirus colds. Ann Intern Med. 88:1978;463-467.
36. Dick E.C., Jennings L.C., Mink K.A., Wartgow C.D., Inhorn S.L. Aerosol transmission of rhinovirus colds. J Infect Dis. 156:1987;442-448.
37. Winther B., Gwaltney J.M. Jr, Mygind N., Turner R.B., Hendley J.O. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA. 256:1986;1763-1767.
38. Douglas R.G. Jr, Lindgren K.M., Couch R.B. Exposure to cold environment and rhinovirus common cold: failure to demonstrate effect. N Engl J Med. 279:1968;742-747.
39. Staunton D.E., Merluzzi V.J., Rothlein R., et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell. 56:1989;849-853.
40. Winther B., Arruda E., Witek T.J., et al. Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection. Arch Otolaryngol Head Neck Surg. 128:2002;131-136.
41. Harris J.M. II, Gwaltney J.M.J.r. Incubation periods of experimental rhinovirus infection and illness. Clin Infect Dis. 23:1996;1287-1290.
42. Hendley J.O., Gwaltney J.M. Jr. Mechanisms of transmission of rhinovirus infections. Epidemiol Rev. 10:1988;243-258.
43. Gwaltney J.M. Jr, Hayden F.G. Psychological stress and the common cold. N Engl J Med. 326:1992;644-645.
44. Gustafson L.M., Proud D., Hendley J.O., Hayden F.G., Gwaltney J.M. Jr. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol. 97:1996;1009-1014.
45. Treanor J.J. Influenza virus. Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious diseases. 5th edn:2000;1823-1849 Churchill Livingstone, Philadelphia.
46. Cherry J.D. Adenoviruses. Feigin R.D., Cherry J.D. Textbook of pediatric infectious diseases. 4th edn:1998;1666-1684 W B Saunders, Philadelphia.
47. Naclerio R.M., Proud D., Lichtenstein L.M., et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 157:1988;133-142.
48. Welliver R.C., Wong D.T., Sun M., et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med. 305:1981;841-846.
49. Volovitz B., Faden H., Ogra P.L. Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr. 112:1988;218-222.
50. Noah T.L., Henderson F.W., Wortman I.A., et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 171:1995;584-592.
51. Fritz R.S., Hayden F.G., Calfee D.P., et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis. 180:1999;586-593.
52. Saito T., Deskin R.W., Casola A., et al. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis. 175:1997;497-504.
53. Zhu Z., Tang W., Ray A., et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro: evidence for nuclear factor κB-dependent transcriptional activation. J Clin Invest. 97:1996;421-430.
54. Turner R.B., Weingand K.W., Yeh C.H., Leedy D.W. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis. 26:1998;840-846.
55. Patel J.A., Jiang Z., Nakajima N., Kunimoto M. Autocrine regulation of interleukin-8 by interleukin-1α in respiratory syncytial virus-infected pulmonary epithelial cells in vitro. Immunology. 95:1998;501-506.
56. Gwaltney J.M. Jr, Phillips C.D., Miller R.D., Riker D.K. Computed tomographic study of the common cold. N Engl J Med. 330:1994;25-30.
57. Puhakka T., Mäkelä M.J., Alanen A., et al. Sinusitis in the common cold. J Allergy Clin Immunol. 102:1998;403-408.
58. Gwaltney J.M. Jr, Hendley J.O., Phillips C.D., et al. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis. 30:2000;387-391.
59. Pitkäranta A., Arruda E., Malmberg H., Hayden F.G. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR. J Clin Microbiol. 35:1997;1791-1793.
60. Pitkäranta A., Starck M., Savolainen S., et al. Rhinovirus RNA in the maxillary sinus epithelium of adult patients with acute sinusitis. Clin Infect Dis. 33:2001;909-911.
61. Heikkinen T. The role of respiratory viruses in otitis media. Vaccine. 19:(suppl 1):2000;S51-S55.
62. Sanyal M.A., Henderson F.W., Stempel E.C., Collier A.M., Denny F.W. Effect of upper respiratory tract infection on Eustachian tube ventilatory function in the preschool child. J Pediatr. 97:1980;11-15.
63. Winther B., Hayden F.G., Arruda E., et al. Viral respiratory infection in schoolchildren: effects on middle ear pressure. Pediatrics. 109:2002;826-832.
64. McBride T.P., Doyle W.J., Hayden F.G., Gwaltney J.M. Jr. Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. Arch Otolaryngol Head Neck Surg. 115:1989;1054-1059.
65. Doyle W.J., Skoner D.P., Hayden F., et al. Nasal and otologic effects of experimental influenza A virus infection. Ann Otol Rhinol Laryngol. 103:1994;59-69.
66. Halperin S.A., Eggleston P.A., Hendley J.O., et al. Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am Rev Respir Dis. 128:1983;806-810.
67. Papadopoulos N.G., Bates P.J., Bardin P.G., et al. Rhinoviruses infect the lower airways. J Infect Dis. 181:2000;1875-1884.
68. Gwaltney J.M. Jr, Hendley J.O., Simon G., Jordan W.S. Jr. Rhinovirus infections in an industrial population, 2: characteristics of illness and antibody response. JAMA. 202:1967;494-500.
69. Puhakka T., Mäkelä M.J., Malmström K., et al. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol. 101:1998;726-731.
70. Igarashi Y., Skoner D.P., Doyle W.J., et al. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol. 92:1993;722-731.
71. Winther B., Brofeldt S., Gronborg H., et al. Study of bacteria in the nasal cavity and nasopharynx during naturally acquired common colds. Acta Otolaryngol. 98:1984;315-320.
72. Putto A., Ruuskanen O., Meurman O. Fever in respiratory virus infections. Am J Dis Child. 140:1986;1159-1163.
73. Dick E.C., Inhorn S.L., Glezen W.P. Rhinoviruses. Feigin R.D., Cherry J.D. Textbook of pediatric infectious diseases. 4th edn:1998;1839-1865 W B Saunders, Philadelphia.
74. Heikkinen T., Ruuskanen O., Ziegler T., Waris M., Puhakka H. Short-term use of amoxicillin-clavulanate during upper respiratory tract infection for prevention of acute otitis media. J Pediatr. 126:1995;313-316.
75. Tapiainen T., Luotonen L., Kontiokari T., Renko M., Uhari M. Xylitol administered only during respiratory infections failed to prevent acute otitis media. Pediatrics. 109:2002;e19.
76. Henderson F.W., Collier A.M., Sanyal M.A., et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med. 306:1982;1377-1383.
77. Ruuskanen O., Arola M., Putto-Laurila A., et al. Acute otitis media and respiratory virus infections. Pediatr Infect Dis J. 8:1989;94-99.
78. Heikkinen T., Ruuskanen O. Temporal development of acute otitis media during upper respiratory tract infection. Pediatr Infect Dis J. 13:1994;659-661.
79. Koivunen P., Kontiokari T., Niemelä M., Pokka T., Uhari M. Time to development of acute otitis media during an upper respiratory tract infection in children. Pediatr Infect Dis J. 18:1999;303-305.
80. Chonmaitree T., Owen M.J., Howie V.M. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis. 162:1990;546-549.
81. Arola M., Ziegler T., Ruuskanen O. Respiratory virus infection as a cause of prolonged symptoms in acute otitis media. J Pediatr. 116:1990;697-701.
82. Pitkäranta A., Virolainen A., Jero J., Arruda E., Hayden F.G. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics. 102:1998;291-295.
83. Heikkinen T., Thint M., Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 340:1999;260-264.
84. Juvén T., Mertsola J., Waris M., et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 19:2000;293-298.
85. Heiskanen-Kosma T., Korppi M., Jokinen C., et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 17:1998;986-991.
86. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ. 307:1993;982-986.
87. Johnston S.L., Pattemore P.K., Sanderson G., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 310:1995;1225-1229.
88. Seemungal T., Harper-Owen R., Bhowmik A., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 164:2001;1618-1623.
89. Greenberg S.B., Allen M., Wilson J., Atmar R.L. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 162:2000;167-173.
90. Ghosh S., Champlin R., Couch R., et al. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis. 29:1999;528-532.
91. Putto A. Febrile exudative tonsillitis: viral or streptococcal? Pediatrics. 80:1987;6-12.
92. Walsh E.E., Falsey A.R., Hennessey P.A. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med. 160:1999;791-795.
93. Carrat F., Tachet A., Rouzioux C., Housset B., Valleron A.J. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis. 28:1999;283-290.
94. Monto A.S., Gravenstein S., Elliott M., Colopy M., Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 160:2000;3243-3247.
95. Waris M., Ziegler T., Kivivirta M., Ruuskanen O. Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. J Clin Microbiol. 28:1990;1159-1162.
96. Kim H.W., Wyatt R.G., Fernie B.F., et al. Respiratory syncytial virus detection by immunofluorescence in nasal secretions with monoclonal antibodies against selected surface and internal proteins. J Clin Microbiol. 18:1983;1399-1404.
97. Nikkari S., Halonen P., Kharitonenkov I., et al. One-incubation time-resolved fluoroimmunoassay based on monoclonal antibodies in detection of influenza A and B viruses directly in clinical specimens. J Virol Methods. 23:1989;29-40.
98. Cox N.J., Subbarao K. Influenza. Lancet. 354:1999;1277-1282.
99. Krilov L.R., Lipson S.M., Barone S.R., et al. Evaluation of a rapid diagnostic test for respiratory syncytial virus (RSV): potential for bedside diagnosis. Pediatrics. 93:1994;903-906.
100. Monto AS, Herlocher ML, Rotthoff J, Bidol SA. Detection and control of influenza outbreaks in Michigan nursing homes. Program and Abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America, San Francisco, USA, 2001; abstr 888.
101. Hyypiä T., Puhakka T., Ruuskanen O., et al. Molecular diagnosis of human rhinovirus infections: comparison with virus isolation. J Clin Microbiol. 36:1998;2081-2083.
102. Fan J., Henrickson K.J., Savatski L.L. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). Clin Infect Dis. 26:1998;1397-1402.
103. McIntosh K., Halonen P., Ruuskanen O. Report of a workshop on respiratory viral infections: epidemiology, diagnosis, treatment, and prevention. Clin Infect Dis. 16:1993;151-164.
104. Hall C.B., Douglas R.G. Jr. Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis. 131:1975;1-5.
105. Covalciuc K.A., Webb K.H., Carlson C.A. Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods. J Clin Microbiol. 37:1999;3971-3974.
106. Heikkinen T., Salmi A.A., Ruuskanen O. Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza. BMJ. 322:2001;138.
107. Smith M.B., Feldman W. Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991. JAMA. 269:1993;2258-2263.
108. Lowenstein S.R., Parrino T.A. Management of the common cold. Adv Intern Med. 32:1987;207-233.
109. Arroll B, Kenealy T. Antibiotics for the common cold (Cochrane Review). The Cochrane Library, Issue 3. Oxford: Update Software, 2002.
110. Sperber S.J., Sorrentino J.V., Riker D.K., Hayden F.G. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull N Y Acad Med. 65:1989;145-160.
111. Gwaltney J.M. Jr, Druce H.M. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin Infect Dis. 25:1997;1188-1194.
112. Hayden F.G., Diamond L., Wood P.B., Korts D.C., Wecker M.T. Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 125:1996;89-97.
113. Farr B.M., Gwaltney J.M. Jr, Hendley J.O., et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis. 162:1990;1173-1177.
114. Ruohola A., Heikkinen T., Waris M., Puhakka T., Ruuskanen O. Intranasal fluticasone propionate does not prevent acute otitis media during viral upper respiratory infection in children. J Allergy Clin Immunol. 106:2000;467-471.
115. Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings (Cochrane Review). The Cochrane Library, Issue 2. Oxford: Update Software, 2002.
116. Sperber S.J., Hendley J.O., Hayden F.G., et al. Effects of naproxen on experimental rhinovirus colds: a randomized, double-blind, controlled trial. Ann Intern Med. 117:1992;37-41.
117. Marshall I. Zinc for the common cold (Cochrane Review). The Cochrane Library, Issue 2. Oxford: Update Software, 2002.
118. Hayden F.G., Belshe R.B., Clover R.D., et al. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med. 321:1989;1696-1702.
119. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet. 352:1998;1877-1881.
120. Nicholson K.G., Aoki F.Y., Osterhaus A.D., et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet. 355:2000;1845-1850.
121. Kaiser L., Keene O.N., Hammond J.M.J., Elliott M., Hayden F.G. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Arch Intern Med. 160:2000;3234-3240.
122. Whitley R.J., Hayden F.G., Reisinger K.S., et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 20:2001;127-133.
123. Hayden F.G., Gwaltney J.M. Jr. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. J Infect Dis. 150:1984;174-180.
124. Hayden F.G., Kaiser D.L., Albrecht J.K. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds. Antimicrob Agents Chemother. 32:1988;224-230.
125. Turner R.B., Wecker M.T., Pohl G., et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA. 281:1999;1797-17804.
126. Schiff G.M., Sherwood J.R. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J Infect Dis. 181:2000;20-26.
127. Kaiser L., Crump C.E., Hayden F.G. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antiviral Res. 47:2000;215-220.
128. Hsyu P.H., Pithavala Y.K., Gersten M., Penning C.A., Kerr B.M. Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. Antimicrob Agents Chemother. 46:2002;392-397.
129. Hayden F.G., Coats T., Kim K., et al. Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials. Antivir Ther. 7:2002;53-65.
130. Gwaltney J.M. Jr. Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis. 166:1992;776-782.
131. Gwaltney J.M. Jr, Winther B., Patrie J.T., Hendley J.O. Combined antiviral-antimediator treatment for the common cold. J Infect Dis. 186:2002;147-154.
132. Belshe R.B., Mendelman P.M., Treanor J., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 338:1998;1405-1412.
133. Nichol K.L., Mendelman P.M., Mallon K.P., et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 282:1999;137-144.
134. Glueck R. Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization. Vaccine. 20:(suppl 1):2001;S42-S44.
135. Crowe J.E. Jr. Respiratory syncytial virus vaccine development. Vaccine. 20:(suppl 1):2001;S32-S37.
136. Lee M.S., Greenberg D.P., Yeh S.H., et al. Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants. J Infect Dis. 184:2001;909-913.
137. Skiadopoulos M.H., Tatem J.M., Surman S.R., et al. The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys. Vaccine. 20:2002;1846-1852.
138. Dolin R., Reichman R.C., Madore H.P., et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 307:1982;580-584.
139. Monto A.S., Robinson D.P., Herlocher M.L., et al. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA. 282:1999;31-35.
140. Hayden F.G., Atmar R.L., Schilling M., et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med. 341:1999;1336-1343.
141. Hayden F.G., Gubareva L.V., Monto A.S., et al. Inhaled zanamivir for the prevention of influenza in families. N Engl J Med. 343:2000;1282-1289.
142. Welliver R., Monto A.S., Carewicz O., et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 285:2001;748-754.
143. Douglas R.M., Moore B.W., Miles H.B., et al. Prophylactic efficacy of intranasal alpha2-interferon against rhinovirus infections in the family setting. N Engl J Med. 314:1986;65-70.
144. Heikkinen T., Ruohola A., Ruuskanen O., et al. Intranasally administered immunoglobulin for the prevention of rhinitis in children. Pediatr Infect Dis J. 17:1998;367-372.
145. Douglas RM, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold (Cochrane Review). The Cochrane Library, Issue 2. Oxford: Update Software, 2002.
146. Melchart D, Linde K, Fischer P, Kaesmayr J. Echinacea for preventing and treating the common cold (Cochrane Review). The Cochrane Library, Issue 2. Oxford: Update Software, 2002.
147. Warshauer D.M., Dick E.C., Mandel A.D., Flynn T.C., Jerde R.S. Rhinovirus infections in an isolated Antarctic station: transmission of the viruses and susceptibility of the population. Am J Epidemiol. 129:1989;319-340.
148. Takkouche B., Regueira-Méndez C., Garcia-Closas R., et al. Intake of wine, beer, and spirits and the risk of clinical common cold. Am J Epidemiol. 155:2002;853-858.